Home
Search
Toolkit for Advocates

Cost & Value of Biopharmaceuticals

Showing 1 - 4 of 4
PDF
The U.S. Bioscience Industry Fosters Innovation and Drives America’s Economy Forward
FLIP
The bioscience industry and its supporting ecosystem drive bold innovations to address unmet human needs in the U.S. and around the world, including developing new breakthrough therapies that treat deadly diseases. The collective efforts of the industry and our public and private stakeholders have met the challenges of the COVID pandemic head-on, while lessening the impacts of climate change and nourishing a growing global population.
DOWNLOAD PDF
VIEW PDF
FLIP
PDF
Private Sector's Critical Role in Biomedical Innovation
FLIP
There is a misguided perception that NIH funding, not private market investment, is largely responsible for the creation and approval of new therapies. A new study by Vital Transformation¹ tests that hypothesis by tracking more than 20,000 patents linked to NIH grant over a 20 year period, identifying those associated with clinical trials and approved medicines, and quantifying the public and private investments made for those investigational and approved medicines.
DOWNLOAD PDF
VIEW PDF
FLIP
This whiteboard video helps break down the experience of a senior in the Medicare Part D program.
Play
Aug 5, 2019
YouTube
Why are seniors paying so much out of pocket for their medicines?
FLIP
Aug 5, 2019
This whiteboard video helps break down the experience of a senior in the Medicare Part D program.
PLAY VIDEO
FLIP
Why are patients facing higher costs when they go to the pharmacy?
Play
Jul 26, 2019
YouTube
Why are patients facing higher costs when they go to the pharmacy?
FLIP
Jul 26, 2019
In this video, you will learn how changes to the way insurance is designed has left some vulnerable patients paying more out of pocket for the medicines they need.
PLAY VIDEO
FLIP